1.Ricci, E, Moraes, CT, Servidei, S, Tonali, P, Bonilla, E, DiMauro, S.Disorders associated with depletion of mitochondrial DNA. Brain Pathol. 1992;2:141–7.
2.Spinazzola, A, Zeviani, M.Disorders of nuclear-mitochondrial intergenomic signaling. Gene. 2005;354:162–8.
3.Dimmock, D, Tang, LY, Schmitt, ES, Wong, LJ.Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem. 2010;56:1119–27.
4.Navarro-Sastre, A, Tort, F, Garcia-Villoria, J, et al.Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients. Mol Genet Metab. 2012;107:409–15.
5.Hakonen, AH, Goffart, S, Marjavaara, S, et al.Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet. 2008;17:3822–35.
6.AlSaman, A, Tomoum, H, Invernizzi, F, Zeviani, M.Hepatocerebral form of mitochondrial DNA depletion syndrome due to mutation in MPV17 gene. Saudi J Gastroenterol. 2012;18:285–9.
7.Moraes, CT, Shanske, S, Tritschler, HJ, et al.mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet. 1991;48:492–501.
8.Poulton, J, Hirano, M, Spinazzola, A, et al.Collated mutations in mitochondrial DNA (mtDNA) depletion syndrome (excluding the mitochondrial gamma polymerase, POLG1). Biochim Biophys Acta. 2009;1792:1109–12.
9.Naviaux, RK, Nguyen, KV.POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion. Ann Neurol. 2005;58:491.
10.Okamura, K, Santa, T, Nagae, K, Omae, T.Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria. J Neurol Sci. 1976;27:79–91.
11.Naviaux, RK, Nyhan, WL, Barshop, BA, et al.Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann Neurol. 1999;45:54–8.
12.Nishino, I, Spinazzola, A, Hirano, M.Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283:689–92.
13.Mandel, H, Szargel, R, Labay, V, et al.The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet. 2001;29:337–41.
14.Saada, A, Shaag, A, Mandel, H, Nevo, Y, Eriksson, S, Elpeleg, O.Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 2001;29:342–4.
15.Elpeleg, O, Miller, C, Hershkovitz, E, et al.Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet. 2005;76:1081–6.
16.Spinazzola, A, Viscomi, C, Fernandez-Vizarra, E, et al.MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet. 2006;38:570–5.
17.Ostergaard, E, Christensen, E, Kristensen, E, et al.Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet. 2007;81:383–7.
18.Bourdon, A, Minai, L, Serre, V, et al.Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet. 2007;39:776–80.
19.Sarzi, E, Goffart, S, Serre, V, et al.Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol. 2007;62:579–87.
20.Jones, SP, Qazi, N, Morelese, J, et al.Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens. J Acquir Immune Defic Syndr. 2005;40:565–72.
21.Kollberg, G, Moslemi, AR, Darin, N, et al.POLG1 mutations associated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol. 2006;65:758–68.
22.de Vries, MC, Rodenburg, RJ, Morava, E, et al.Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. Eur J Pediatr. 2007;166:229–34.
23.Fellman, V, Kotarsky, H.Mitochondrial hepatopathies in the newborn period. Semin Fetal Neonatal Med. 2011;16:222–8.
24.Uusimaa, J, Hinttala, R, Rantala, H, et al.Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus. Epilepsia. 2008;49:1038–45.
25.Ashley, N, O'Rourke, A, Smith, C, et al.Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations. Hum Mol Genet. 2008;17:2496–506.
26.Scalais, E, Francois, B, Schlesser, P, et al.Polymerase gamma deficiency (POLG): clinical course in a child with a two stage evolution from infantile myocerebrohepatopathy spectrum to an Alpers syndrome and neuropathological findings of Leigh's encephalopathy. Eur J Paediatr Neurol. 2012;16:542–8.
27.Saneto, RP, Naviaux, RK.Polymerase gamma disease through the ages. Dev Disabil Res Rev. 2010;16:163–74.
28.Stewart, JD, Tennant, S, Powell, H, et al.Novel POLG1 mutations associated with neuromuscular and liver phenotypes in adults and children. J Med Genet. 2009;46:209–14.
29.Tzoulis, C, Papingji, M, Fiskestrand, T, Roste, LS, Bindoff, LA.Mitochondrial DNA depletion in progressive external ophthalmoplegia caused by POLG1 mutations. Acta Neurol Scand Suppl. 2009;189:38–41.
30.Mehta, AR, Fox, SH, Tarnopolsky, M, Yoon, G.Mitochondrial mimicry of multiple system atrophy of the cerebellar subtype. Mov Disord. 2011;26:753–5.
31.Ferrari, G, Lamantea, E, Donati, A, et al.Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain. 2005;128:723–31.
32.Chan, SS, Longley, MJ, Naviaux, RK, Copeland, WC.Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome. DNA Repair (Amst). 2005;4:1381–9.
33.Nguyen, KV, Sharief, FS, Chan, SS, Copeland, WC, Naviaux, RK.Molecular diagnosis of Alpers syndrome. J Hepatol. 2006;45:108–16.
34.Haudry, C, de Lonlay, P, Malan, V, et al.Maternal uniparental disomy of chromosome 2 in a patient with a DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome. Mol Genet Metab. 2012;107:700–4.
35.Nobre, S, Grazina, M, Silva, F, Pinto, C, Goncalves, I, Diogo, L. Neonatal liver failure due to deoxyguanosine kinase deficiency. BMJ Case Rep. 2012;(in press).
36.Scaglia, F, Dimmock, D, Wong, LJ.DGUOK-related mitochondrial DNA depletion syndrome, hepatocerebral form. 2009 Jun 18. In: Pagon, RA, Bird, TD, Dolan, CR, Stephens, K, Adam, MP, editors. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from http://www.ncbi.nlm.nih.gov/books/NBK7040/
37.Kasapkara, CS, Tümer, L, Küçükçongar, A, Hasanoğlu, A, Seneca, S, De Meirleir, L. Dguok related mitochondrial depletion syndrome in a child with an early diagnosis of GSD. J Pediatr Gastroenterol Nutr. 2012;(in press)
38.Freisinger, P, Fütterer, N, Lankes, E, et al.Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch Neurol. 2006;63:1129–34.
39.Mousson de Camaret, B, Taanman, JW, Padet, S, Chassagne, M, et al.Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion. Biochem J. 2007;402:377–85.
40.Kiliç, M, Sivri, HS, Dursun, A, et al.A novel mutation in the DGUOK gene in a Turkish newborn with mitochondrial depletion syndrome. Turk J Pediatr. 2011;53:79–82.
41.Pronicka, E, Węglewska-Jurkiewicz, A, Taybert, J, et al.Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure. J Appl Genet. 2011;52:61–6.
42.Brahimi, N, Jambou, M, Sarzi, E, et al.The first founder DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome. Mol Genet Metab. 2009;97:221–6.
43.Ronchi, D, Garone, C, Bordoni, A, et al.Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions. Brain. 2012;135:3404–15.
44.Douglas, GV, Wiszniewska, J, Lipson, MH, et al.Detection of uniparental isodisomy in autosomal recessive mitochondrial DNA depletion syndrome by high-density SNP array analysis. J Hum Genet. 2011;56:834–9.
45.Collins, J, Bove, KE, Dimmock, D, Morehart, P, Wong, LJ, Wong, B.Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations. Neuromuscul Disord. 2009;19:784–7.
46.Bartesaghi, S, Betts-Henderson, J, Cain, K, et al.Loss of thymidine kinase 2 alters neuronal bioenergetics and leads to neurodegeneration. Hum Mol Genet. 2010;19:1669–77.
47.Götz, A, Isohanni, P, Pihko, H, et al.Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. Brain. 2008;131:2841–50.
48.Lesko, N, Naess, K, Wibom, R, et al.Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion. Neuromuscul Disord. 2010;20:198–203.
49.Zhang, S, Li, FY, Bass, HN, et al.Application of oligonucleotide array CGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion. Mol Genet Metab. 2010;99: 53–7.
50.Béhin, A, Jardel, C, Claeys, KG, et al.Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum. Neurology. 2012;78:644–8.
51.Mancuso, M, Filosto, M, Bonilla, E, et al.Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene. Arch Neurol. 2003;60:1007–9.
52.Galbiati, S, Bordoni, A, Papadimitriou, D, et al.New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr Neurol. 2006;34:177–85.
53.Rohrbach, M, Chitayat, D, Maegawa, G, et al.Intracerebral periventricular pseudocysts in a fetus with mitochondrial depletion syndrome: an association or coincidence. Fetal Diagn Ther. 2009;25:177–82.
54.Martí, R, Nascimento, A, Colomer, J, et al.Hearing loss in a patient with the myopathic form of mitochondrial DNA depletion syndrome and a novel mutation in the TK2 gene. Pediatr Res. 2010;68:151–4.
55.Oskoui, M, Davidzon, G, Pascual, J, et al.Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol. 2006;63:1122–6.
56.Blakely, E, He, L, Gardner, JL, et al.Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy. Neuromuscul Disord. 2008;18:557–60.
57.Vilà, MR, Villarroya, J, García-Arumí, E, et al.Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency. J Neurol Sci. 2008;267:137–41.
58.Béhin, A, Jardel, C, Claeys, KG, et al.Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum. Neurology. 2012;78:644–8.
59.Tyynismaa, H, Sun, R, Ahola-Erkkilä, S, et al.Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet. 2012;21:66–75.
60.Wang, L, Limongelli, A, Vila, MR, Carrara, F, Zeviani, M, Eriksson, S.Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes. Mol Genet Metab. 2005;84:75–82.
61.Leshinsky-Silver, E, Michelson, M, Cohen, S, et al.A defect in the thymidine kinase 2 gene causing isolated mitochondrial myopathy without mtDNA depletion. Eur J Paediatr Neurol. 2008;12:309–13.
62.Durham, SE, Bonilla, E, Samuels, DC, DiMauro, S, Chinnery, PF.Mitochondrial DNA copy number threshold in mtDNA depletion myopathy. Neurology. 2005;65:453–5.
63.Parini, R, Furlan, F, Notarangelo, L, et al.Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. J Hepatol. 2009;50:215–21.
64.Spinazzola, A, Santer, R, Akman, OH, et al.Hepatocerebral form of mitochondrial DNA depletion syndrome: novel MPV17 mutations. Arch Neurol. 2008;65(8)
65.Wong, LJ, Brunetti-Pierri, N, Zhang, Q, et al.Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology. 2007;46:1218–27.
66.Navarro-Sastre, A, Martin-Hernandez, E, Campos, Y, et al.Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form. Mol Genet Metab. 2008;94:234–9.
67.Kaji, S, Murayama, K, Nagata, I, et al.Fluctuating liver functions in siblings with MPV17 mutations and possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain complex II. Mol Genet Metab. 2009;97:292–6.
68.Karadimas, CL, Vu, TH, Holve, SA, et al.Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet. 2006;79:544–8.
69.El-Hattab, AW, Li, FY, Schmitt, E, Zhang, S, Craigen, WJ, Wong, LJ.MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations. Mol Genet Metab. 2010;99:300–8.
70.Garone, C, Rubio, JC, Calvo, SE, et al.MPV17 mutations causing adult-onset multisystemic disorder with multiple mitochondrial DNA deletions. Arch Neurol. 2012:1–4.
71.Merkle, AN, Nascene, DR, McKinney, AM.MR imaging findings in the reticular formation in siblings with MPV17-related mitochondrial depletion syndrome. Am J Neuroradiol. 2012;33:E34–5.
72.Hirano, M, Marti, R, Casali, C, et al.Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology. 2006;67: 1458–60.
73.Slama, A, Lacroix, C, Plante-Bordeneuve, V, et al.Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome. Mol Genet Metab. 2005;84:326–31.
74.Giordano, C, Sebastiani, M, De Giorgio, R, et al.Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalo-myopathy is caused by mitochondrial DNA depletion. Am J Pathol. 2008;173:1120–8.
75.Massa, R, Tessa, A, Margollicci, M, et al.Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity. Neuromuscul Disord. 2009;19:837–40.
76.Garone, C, Tadesse, S, Hirano, M.Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain. 2011;134:3326–32.
77.Laforce, R Jr, Valdmanis, PN, Dupre, N, Rouleau, GA, Turgeon, AF, Savard, M.A novel TYMP mutation in a French Canadian patient with mitochondrial neurogastrointestinal encephalomyopathy. Clin Neurol Neurosurg. 2009;111:691–4.
78.Cardaioli, E, Da Pozzo, P, Malfatti, E, et al.A second MNGIE patient without typical mitochondrial skeletal muscle involvement. Neurol Sci. 2010;31:491–4.
79.Carrozzo, R, Dionisi-Vici, C, Steuerwald, U, et al.SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain. 2007;130:862–74.
80.Ostergaard, E.SUCLA2-related mitochondrial DNA depletion syndrome, encephalomyopathic form, with mild methylmalonic aciduria. 2009 May 26. In: Pagon, RA, Bird, TD, Dolan, CR, Stephens, K, Adam, MP, editors. GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from http://www.ncbi.nlm.nih.gov/books/NBK6803/
81.Lamperti, C, Fang, M, Invernizzi, F, et al.A novel homozygous mutation in SUCLA2 gene identified by exome sequencing. Mol Genet Metab. 2012;107:403–8.
82.Rouzier, C, Le Guédard-Méreuze, S, Fragaki, K, et al.The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein. J Med Genet. 2010;47:670–6.
83.Ostergaard, E, Schwartz, M, Batbayli, M, et al.A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria. Eur J Pediatr. 2010;169:201–5.
84.Valayannopoulos, V, Haudry, C, Serre, V, et al.New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria. Mitochondrion. 2010;10:335–41.
85.Rivera, H, Merinero, B, Martinez-Pardo, M, et al.Marked mitochondrial DNA depletion associated with a novel SUCLG1 gene mutation resulting in lethal neonatal acidosis, multi-organ failure, and interrupted aortic arch. Mitochondrion. 2010;10:362–8.
86.Sakamoto, O, Ohura, T, Murayama, K, et al.Neonatal lactic acidosis with methylmalonic aciduria due to novel mutations in the SUCLG1 gene. Pediatr Int. 2011;53:921–5.
87.Shaibani, A, Shchelochkov, OA, Zhang, S, Katsonis, P, Lichtarge, O, Wong, LJ, Shinawi, M.Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol. 2009;66:1028–32.
88.Bornstein, B, Area, E, Flanigan, KM, et al.Mitochondrial DNA depletion syndrome due to mutations in the RRM2B gene. Neuromuscul Disord. 2008;18:453–9.
89.Pitceathly, RD, Smith, C, Fratter, Cet al.Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain. 2012;135:3392–403.
90.Pitceathly, RD, Fassone, E, Taanman, JW, et al.Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. J Med Genet. 2011;48:610–7.
91.Kollberg, G, Darin, N, Benan, K, et al.A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion. Neuromuscul Disord. 2009;19:147–50.
92.Acham-Roschitz, B, Plecko, B, Lindbichler, F, et al.A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy. Mol Genet Metab. 2009;98:300–4.
93.Sarzi, E, Goffart, S, Serre, V, et al.Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol. 2007;62:579–87.
94.Hakonen, AH, Isohanni, P, Paetau, A, Herva, R, Suomalainen, A, Lonnqvist, T.Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain. 2007;130:3032–40.
95.Lönnqvist, T, Paetau, A, Valanne, L, Pihko, H.Recessive twinkle mutations cause severe epileptic encephalopathy. Brain. 2009;132:1553–62.
96.Elachouri, G, Vidoni, S, Zanna, C, et al.OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res. 2011;21:12–20.
97.Nasi, M, Pinti, M, Chiesa, E, et al.Target Study Group. Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery. Antivir Ther. 2011;16:365–72.
98.Pinti, M, Gibellini, L, Guaraldi, G, et al.Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease. AIDS. 2010;24:841–50.
99.McComsey, GA, Libutti, DE, O'Riordan, M, et al.Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection. Antivir Ther. 2008;13:715–22.
100.Honzík, T, Tesarová, M, Hansíková, H, et al.Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Cas Lek Cesk. 2006;145:665–70.
101.Laforce, R Jr, Valdmanis, PN, Dupré, N, Rouleau, GA, Turgeon, AF, Savard, M.A novel TYMP mutation in a French Canadian patient with mitochondrial neurogastrointestinal encephalomyopathy. Clin Neurol Neurosurg. 2009;111:691–4.
102.Douglas, GV, Wiszniewska, J, Lipson, MH, et al.Detection of uniparental isodisomy in autosomal recessive mitochondrial DNA depletion syndrome by high-density SNP array analysis. J Hum Genet. 2011;56:834–9.
103.Bulst, S, Abicht, A, Holinski-Feder, E, et al.Horvath R. In vitro supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes. Hum Mol Genet. 2009;18:1590–9.